Abstract
Elderly patients are characterized by the presence of several diseases at once (polymorbidity). This is due to the simultaneous appointment of several drugs (polypharmacy) to such patients. But at the same time, polypharmacy reduces the effectiveness of treatment and increases the risk of adverse reactions. Therefore, it is extremely important to select drugs individually in compliance with the indications and contraindications for their appointment, to take into account the interaction of drugs and the possibility of the drug's influence on concomitant pathology, to use only proven effectiveness and safety drugs, to guide by Beer's criteria, to unexceed the recommended doses, to include in complex therapy metabolic drugs to optimize elderly patients drug therapy. Keywords: elderly patients; geriatrics; pharmacotherapy; polymorbidity; polypharmacy; Beers criteria
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
